Genetic repair of muscle problems in Duchenne muscular dystrophy (DMD)
Official title: Genetic repair of muscular degeneration associated with Duchenne muscular dystrophy
Funded at Illinois State University · NIH-11360475 · Data updated 2026-11-12
Aims to improve muscle and organ function in people with Duchenne muscular dystrophy by testing genetic repair approaches and smooth muscle therapies.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Illinois State University NIH-funded |
| Lab location | 1 site (Normal, United States) |
| Project start | August 1, 2026 |
| Project end | July 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $544,734 |
| NIH project number | 1R15AR087731-01 |
| Project ID | NIH-11360475 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with Duchenne muscular dystrophy or related genetic muscle disorders who experience smooth muscle and gastrointestinal problems.
✕Less likely to help
Individuals without Duchenne muscular dystrophy or without associated smooth muscle/gastrointestinal symptoms may not benefit from this specific research.
What this research studies
This project looks at Duchenne muscular dystrophy, a genetic condition that damages muscles, and explores how to fix the underlying genetic issue while also targeting smooth muscle problems in organs like the bladder and gut. Researchers will study a model organism, C. elegans, alongside human smooth muscle cells to understand how muscles beyond the skeleton are affected. The work uses advanced imaging and gene profiling to see how smooth muscles respond to potential therapies, including microdystrophin constructs and corticosteroids. By linking findings in model systems to human cells, the team aims to identify approaches that could improve both movement and gastrointestinal function for patients.
Why it matters
Potential benefit: If successful, the research could lead to therapies that help both skeletal and smooth muscles in people with DMD, potentially improving mobility and quality of life.
How similar studies have gone: Preliminary work suggests corticosteroids help skeletal muscle but not smooth muscle dysfunction, indicating a need for targeted therapies.
Where this research is happening
-
Illinois State University
Normal, United States Active
Researchers
- Principal investigator: Vidal Gadea, Andres Gabriel — Illinois State University
- Study coordinator: Vidal Gadea, Andres Gabriel
Related research
Other NIH-funded projects on the same topics.
-
Advancing manufacturing and release testing for a Duchenne gene editing therapy
A project to optimize how a dual-vector AAV gene editing treatment for Duchenne muscular dystrophy is made and tested, so it can move toward clinical use.
-
Understanding why Duchenne Muscular Dystrophy worsens and how to stop it
A research team at USC is studying Duchenne muscular dystrophy to find out why the disease continues to progress and how to interrupt harmful changes in muscle tissue.
-
Stopping steroid-related muscle and bone wasting in Duchenne muscular dystrophy
Researchers are testing ways to protect muscles and bones in people with Duchenne muscular dystrophy who take long-term steroid medicines.
-
MR clues to how nNOS affects energy use and blood flow in Becker and Duchenne muscular dystrophy
This project looks at how advanced MRI tests can track muscle energy and blood flow changes in people with Becker and Duchenne muscular dystrophy as new gene therapies are explored.
-
Digital motor-skill tracking for infants with Duchenne Muscular Dystrophy using wearables
A wearable-sensor project aims to quietly track and quantify how motor skills develop in babies and young boys with Duchenne Muscular Dystrophy.
-
Genetic factors that influence Duchenne Muscular Dystrophy progression
A study to find genes that change how severe Duchenne muscular dystrophy is in boys and young men, using patient data and DNA samples.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.